On recent actions and plans of the FDA relevant to the management of patients with allergic disease.
D000942:Antigens, Bacterial / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D007880:Legislation, Drug; D014481:United States; D014486:United States Food and Drug Administration
D000942:Antigens, Bacterial